Olga Pasternak-Wise to Chemoradiotherapy
This is a "connection" page, showing publications Olga Pasternak-Wise has written about Chemoradiotherapy.
Connection Strength
0.201
-
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial. JAMA Oncol. 2025 May 01; 11(5):492-501.
Score: 0.201